Aptamer Renews Contract with Unilever

September 03, 2024 05:55 PM MSK | By Team Kalkine Media
 Aptamer Renews Contract with Unilever
Image source: shutterstock

On Tuesday, Aptamer (LSE:APTA), a company specializing in custom antibody alternatives, announced the extension of its contract with Unilever to advance the development of its Optimer asset for deodorant applications. This renewed agreement marks a new phase in the partnership, focusing on initiating in-vivo efficacy testing for Optimer binders as active ingredients in deodorant products.

The collaboration, which began in 2022, is designed to explore the potential of Optimer binders in creating innovative deodorant solutions. Aptamer reported that the extension follows successful results from lab-based tests of these binders. The next steps involve progressing to planned in-vivo studies to assess the effectiveness of the Optimer binders in real-world scenarios before the end of 2024.

According to Aptamer, the binders have shown consistent and effective enzyme inhibition through extensive testing conducted at both Aptamer's and Unilever’s facilities. This progress highlights the potential for incorporating Optimer binders into deodorant products. The company has also refined these binders to enhance their performance and manufacturability for Unilever’s production needs.

Unilever will now advance the development of the Optimer binders through its internal testing processes and aims to start the in-vivo efficacy studies within the year. A positive outcome from these trials would pave the way for further developments in the ongoing partnership.

Following the announcement, Aptamer’s share price saw a 4.78% increase, reaching 0.24p as of 1300 BST.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.